Literature DB >> 26779762

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA.

Hemant Suryawanshi1, Mayuresh Anant Sarangdhar2, Manika Vij2, Reema Roshan1, Vijay Pal Singh1, Munia Ganguli1, Beena Pillai3.   

Abstract

MicroRNAs (miRNAs) are key regulators of gene expression. In the brain, vital processes like neurodevelopment and neuronal functions depend on the correct expression of microRNAs. Perturbation of microRNAs in the brain can be used to model neurodegenerative diseases by modulating neuronal cell death. Currently, stereotactic injection is used to deliver miRNA knockdown agents to specific location in the brain. Here, we discuss strategies to design antagomirs against miRNA with locked nucleotide modifications (LNA). Subsequently describe a method for brain specific delivery of antagomirs, uniformly across different regions of the brain. This method is simple and widely applicable since it overcomes the surgery, associated injury and limitation of local delivery in stereotactic injections. We prepared a complex of neurotropic, cell-penetrating peptide Rabies Virus Glycoprotein (RVG) with antagomir against miRNA-29 and injected through tail vein, to specifically deliver in the brain. The antagomir design incorporated features that allow specific targeting of the miRNA and formation of non-covalent complexes with the peptide. The knock-down of the miRNA in neuronal cells, resulted in apoptotic cell death and associated behavioural defects. Thus, the method can be used for acute models of neuro-degeneration through the perturbation of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26779762      PMCID: PMC4780854          DOI: 10.3791/53307

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

Review 1.  MicroRNAs in disease and potential therapeutic applications.

Authors:  Harris S Soifer; John J Rossi; Pål Saetrom
Journal:  Mol Ther       Date:  2007-09-18       Impact factor: 11.454

2.  Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome.

Authors:  Shahar Barbash; Geula Hanin; Hermona Soreq
Journal:  J Vis Exp       Date:  2013-06-10       Impact factor: 1.355

Review 3.  The promise of microRNA replacement therapy.

Authors:  Andreas G Bader; David Brown; Matthew Winkler
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

4.  Thermodynamics of DNA-RNA heteroduplex formation: effects of locked nucleic acid nucleotides incorporated into the DNA strand.

Authors:  Harleen Kaur; Jesper Wengel; Souvik Maiti
Journal:  Biochemistry       Date:  2008-01-03       Impact factor: 3.162

5.  Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.

Authors:  Li-Li Zou; Jie-Lan Ma; Tao Wang; Tang-Bin Yang; Chang-Bai Liu
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

6.  Inhibition of microRNA function by antimiR oligonucleotides.

Authors:  Jan Stenvang; Andreas Petri; Morten Lindow; Susanna Obad; Sakari Kauppinen
Journal:  Silence       Date:  2012-01-09

7.  A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.

Authors:  Stephan J Guyenet; Stephanie A Furrer; Vincent M Damian; Travis D Baughan; Albert R La Spada; Gwenn A Garden
Journal:  J Vis Exp       Date:  2010-05-21       Impact factor: 1.355

8.  Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.

Authors:  Reema Roshan; Shruti Shridhar; Mayuresh A Sarangdhar; Arpita Banik; Mrinal Chawla; Manali Garg; Vijay P A L Singh; Beena Pillai
Journal:  RNA       Date:  2014-06-23       Impact factor: 4.942

9.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

Review 10.  Nonviral approaches for neuronal delivery of nucleic acids.

Authors:  Jamie M Bergen; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Pharm Res       Date:  2007-10-12       Impact factor: 4.200

View more
  2 in total

Review 1.  Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders.

Authors:  Bhaskar Roy; Yuta Yoshino; Lauren Allen; Kevin Prall; Grant Schell; Yogesh Dwivedi
Journal:  Mol Diagn Ther       Date:  2020-06       Impact factor: 4.074

2.  Blockade of Indoleamine 2, 3-dioxygenase 1 ameliorates hippocampal neurogenesis and BOLD-fMRI signals in chronic stress precipitated depression.

Authors:  Lei Gao; Tingting Gao; Ting Zeng; Peng Huang; Nai-Kei Wong; Zhaoyang Dong; Yunjia Li; Guanghui Deng; Zhiyong Wu; Zhiping Lv
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.